AusPAR: Avanafil

Australian Public Assessment Report

AusPAR

AusPAR Avanafil [PDF, 760.61 KB]

AusPAR Avanafil [Word, 533.1 KB]

Attachment: Product Information: Avanafil [PDF, 345.36 KB]

Attachment: Product Information: Avanafil [Word, 93.93 KB]

Attachment: Extract from Clinical Evaluation Report: Avanafil [PDF, 4.37 MB]

Attachment: Extract from Clinical Evaluation Report: Avanafil [Word, 11.61 MB]

Device/Product Name

Spedra

Active ingredients

Avanafil

AusPAR Date

27 October 2016

Published

8 November 2016

Submission Number

PM-2014-02782-1-3

Submission Type

New chemical entity

Decision

Approved